Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
With a market cap of 14.11B, Halozyme Therapeutics(HALO) trades at $124.29. The stock has a price-to-earnings ratio of 37.21.
As of 2026-10-23, Halozyme Therapeutics(HALO) stock has fluctuated between $123.74 and $125.02. The current price stands at $124.29, placing the stock +0.4% above today's low and -0.6% off the high.
The Halozyme Therapeutics(HALO)'s current trading volume is 113.38K, compared to an average daily volume of 2.45M.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $125.43 and a 52-week low of $61.23.
In the last year, Halozyme Therapeutics(HALO) shares hit a 52-week high of $125.43 and a 52-week low of $61.23.
HALO News
Halozyme Therapeutics has seen analyst consensus EPS estimates for the current year raised by 10.2% over the past three months, alongside a Zacks Rank #1 rating...
Advertisement Why Halozyme Therapeutics Just Drew Fresh Attention Halozyme Therapeutics (HALO) is back in focus after expanding its global collaboration and l...
Analyst ratings
73%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.